Reductions in endometriosis-associated pain among elagolix-treated women are consistent across a range of baseline characteristics
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This study found that elagolix treatment effectively reduced endometriosis-associated pain across diverse patient populations, regardless of baseline characteristics.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment 2019
- Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches 2020
- Elagolix in endometriosis-related pain: a profile of its use as approved in the USA 2019
Cited by (3)
- Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches 2020
- Elagolix in endometriosis-related pain: a profile of its use as approved in the USA 2019
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment 2019
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK